We are conducting a new research study for people with Heart Disease* and who are overweight.
Participating in a clinical study can improve future treatment options!
Research has shown that treatment with semaglutide may reduce the risk of stroke and heart attack in people with type 2 diabetes in a study called SELECT. The purpose of this research study is to see if semaglutide reduces the risk of cardiovascular events such as heart attack and stroke in people that are overweight or obese.
You may be eligible if you:
- Are 45 years or older
- Have had a brain attack (stroke), or heart attack (myocardial infarction), or have poor circulation (peripheral arterial disease)
- Are overweight or obese
There are additional criteria to meet to qualify for this study. Volunteers who qualify for our study will receive study related medication, medical exams and procedures at no cost, as well as reimbursement for time and travel. No health insurance is required to participate.
* Have had a brain attack (stroke), or heart attack (myocardial infarction), or have poor circulation (peripheral arterial disease)
For more information call:
Or sign up and our office will call you!